For some, the dual-agonist mechanism of Mounjaro provides the perfect balance of efficacy and tolerability, while others may find the single-agonist Wegovy 7.2mg dose, introduced on January 12, 2026, more suitable for their specific metabolic architecture
The price of GLP-1 drugs has attracted the scrutiny of lawmakers, and Novo Nordisk's chief executive Lars Fruergaard Jrgensen has agreed to appear at a Senate hearing next week to defend the pricing of the group's semaglutide-based therapies
Pros High purity level, over 98% for effective use
The format allows for convenient storage, controlled handling, and ease of integration into existing workflows
If it is still sealed, just put it back in the fridge
Despite the patent for NovoMix having expired in 2014, the premixed insulin analog continues to do well for Novo